Glancy prongay & murray llp, a leading securities fraud law firm, announces the filing of a securities class action on behalf of acelrx pharmaceuticals, inc. (acrx) investors

Los angeles--(business wire)---- $acrx #classaction--glancy prongay & murray llp (“gpm”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired acelrx pharmaceuticals, inc. (“acelrx” or the “company”) (nasdaq: acrx) securities between march 17, 2020 and february 12, 2021, inclusive (the “class period”). acelrx investors have until august 9, 2021 to file a lead plaintiff motion. if you suffered a loss on your
ACRX Ratings Summary
ACRX Quant Ranking